Clinical Trials Browser

Interventional × Pancreatic Neoplasms × temsirolimus × Clear all

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Pancreatic Neoplasms, Colorectal Neoplasms

NCT01183663 2016-06-03

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

BreastCNSDermatologicGastrointestinalGenitourinaryOther hematologic neoplasmPlasma cell

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Glioblastoma, Melanoma, Multiple Myeloma, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

NCT00075647 2013-01-17

CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Phase 2 Completed

40 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT00593008 2011-12-02

Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer

Phase 1 Terminated

5 enrolled

Gastrointestinal

Pancreatic Neoplasms

Clinical Trials

NivoPlus

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer